Farnaby Research Group
@farnabygroup.bsky.social
67 followers 47 following 10 posts
Chemical innovation for CNS diseases
Posts Media Videos Starter Packs
farnabygroup.bsky.social
Special mentions to @nurkocaturk.bsky.social and @holmqvist89.bsky.social for driving this project, key collaborators Calum Sutherland and Kevin Read and their groups in Dundee and our awesome collaborators and supporters at @biotechne.bsky.social
farnabygroup.bsky.social
A key learning: modest brain penetration combined with rapid on-target degradation kinetics was sufficient for activity in brain, highlighting opportunities for those who want to degrade proteins in the CNS and perhaps cautions for those who don’t. 6/7
farnabygroup.bsky.social
Further profiling validated our best hits as cellular and in vivo quality degrader probes that we hope will help researchers further understand this target implicated in several neurodegenerative disease related pathways. 5/7
farnabygroup.bsky.social
Once we had the assay, method and linker toolbox established we synthesised, screened and analysed data, from scratch, in 5 days, to identify potential hits. 4/7
farnabygroup.bsky.social
We used a new approach we called ‘orthogonally reactive linker screening’, to vary all elements of a bifunctional via multi-step synthesis in a well: E3 binder, POI binder, linker and conjugation chemistry. We did this in context of discovering GSK3 degraders. 3/7
farnabygroup.bsky.social
If you like TPD, direct-to-biology approaches, new chemical probe methods, induced proximity or Central Nervous System drug discovery then this is for you! 2/7
farnabygroup.bsky.social
Farnaby research group is on BlueSky now. Keep following our group updates!